These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21170084)

  • 1. BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma.
    Hsu JH; Lawlor ER
    Oncogene; 2011 Apr; 30(17):2077-85. PubMed ID: 21170084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.
    Douglas D; Hsu JH; Hung L; Cooper A; Abdueva D; van Doorninck J; Peng G; Shimada H; Triche TJ; Lawlor ER
    Cancer Res; 2008 Aug; 68(16):6507-15. PubMed ID: 18701473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
    Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
    J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.
    Cooper A; van Doorninck J; Ji L; Russell D; Ladanyi M; Shimada H; Krailo M; Womer RB; Hsu JH; Thomas D; Triche TJ; Sposto R; Lawlor ER
    Clin Cancer Res; 2011 Jan; 17(1):56-66. PubMed ID: 21047978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
    Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
    J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
    Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
    Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
    Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/Frizzled signaling in Ewing sarcoma.
    Uren A; Wolf V; Sun YF; Azari A; Rubin JS; Toretsky JA
    Pediatr Blood Cancer; 2004 Sep; 43(3):243-9. PubMed ID: 15266408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing sarcoma family of tumors.
    Khoury JD
    Adv Anat Pathol; 2005 Jul; 12(4):212-20. PubMed ID: 16096383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
    Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.
    Fu D; Lv X; Hua G; He C; Dong J; Lele SM; Li DW; Zhai Q; Davis JS; Wang C
    Endocr Relat Cancer; 2014 Apr; 21(2):297-310. PubMed ID: 24389730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
    Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
    Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
    Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
    Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
    Kang HG; Jenabi JM; Zhang J; Keshelava N; Shimada H; May WA; Ng T; Reynolds CP; Triche TJ; Sorensen PH
    Cancer Res; 2007 Apr; 67(7):3094-105. PubMed ID: 17409416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
    Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
    PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
    Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.
    Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
    Oncogene; 2013 Mar; 32(11):1441-51. PubMed ID: 22641220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.